Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.6250 (-1.79%) ($15.5300 - $15.6250) on Wed. Jul. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.64% (three month average) | RSI | 36 | Latest Price | $15.6250(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(38%) ARKK(37%) ARKG(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.32% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) TBT(-2%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.32% (StdDev 4.64%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $10.46(-33.06%) | Resistance Level | $16.22 | 5 Day Moving Average | $15.99(-2.28%) | 10 Day Moving Average | $16.06(-2.71%) | 20 Day Moving Average | $16.22(-3.67%) | To recent high | -9.3% | To recent low | 53.4% | Market Cap | $2.757b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |